Global Director, Advocacy & Market Development

Adana, Adıyaman, Afyon, Ağrı, Aksaray, Amasya, Ankara, Antalya, Ardahan, Artvin, Aydın, Balıkesir, Bartın, Batman, Bayburt, Bilecik, Bingöl, Bitlis, Bolu, Burdur, Bursa, Çanakkale, Çankırı, Çorum, Denizli, Diyarbakır, Düzce, Edirne, Elazığ, Erzincan, Erzurum, Eskişehir, Gaziantep, Giresun, Gümüşhane, Hakkari, Hatay, Iğdır, Isparta, İstanbul(Asya), İstanbul(Avr.), İzmir, Kahramanmaraş, Karabük, Karaman, Kars, Kastamonu, Kayseri, Kırıkkale, Kırklareli, Kırşehir, Kilis, Kocaeli, Konya, Kütahya, Malatya, Manisa, Mardin, Mersin, Muğla, Muş, Nevşehir, Niğde, Ordu, Osmaniye, Rize, Sakarya, Samsun, Siirt, Sinop, Sivas, Şanlıurfa, Şırnak, Tekirdağ, Tokat, Trabzon, Tunceli, Uşak, Van, Yalova, Yozgat, Zonguldak
1 gün önce yayınlandı info
Tam Zamanlı Diğer
İlk başvuranlardan ol!
Benzer ilanları keşfetmek için iş alarmı kur
Market Görevlisiİstanbul(Asya) +80 il daha

İş İlanı Hakkında

The Global Director, Advocacy & Market Development (Biologics) leads the global advocacy for severe asthma and non - branded market development agenda . The role is responsible for : Building credible, science - led advocacy across pulmonology and immunology communities with a strong focus on Eosinophilic Inflammation Leading global non-branded market development initiatives to improve diagnosis, optimize care pathways, and enable sustained biologic adoption, focused on International markets and China. Partnering closely with Medical, Commercial and priority markets to translate strategy into measurable impact and scalable execution. This position reports into Global Commercial Head Fasenra and operates in close alignment with Medical Affairs and Key Market Teams. Global Advocacy Program (Eosinophilic Inflammation ) : Lead a global, science-driven advocacy program that mobilizes the respiratory and immunology communities around improved patient outcomes in eosinophilic diseases (Severe Asthma, EGPA and HES) Develop and execute the global Fasenra advocacy strategy aligned with brand strategy and lifecycle priorities Build and evolve trusted relationships with Key External Experts (KEEs) through the Global EOS Science Group and respiratory disease forums Shape and amplify the eosinophilic inflammation narrative in close collaboration with Global Medical and Brand teams, ens uring it’s credible, consistent, and locally actionable Co-create scientific advocacy content and external education initiatives, in partnership with Medical Affairs Market Development Program (Unbranded) : Lead the non-branded market development agenda to help redefine severe asthma care and accelerate adoption of biologic-ready patient pathways. Lead the global non-branded market d evelopment strategy to ensure bio-eligible patients will have access to biological treatment options Identify and address key barriers across the patient journey optimizing diagnosis, referral and Guideline Directed Medical Therapy Partner with Medical, Access and Health Economics teams to co-create priority system change initiatives Collaborate with respiratory authorities, KEEs, and relevant policymakers to strengthen healthcare system capacity and guideline/pathway implementation across key markets, with a particular focus on the International Region and China Translate strategic ambitions into clear global frameworks that markets can localize and execute Cross-functional and Matrix Leadership Act as a global integrator and catalyst across Brand, Medical, Policy/Access, Digital, and priority markets to enable strong global - to - local execution . Align stakeholders on priorities, simplify complexity, and drive focused execution against the most impactful levers Represent advocacy and market development perspectives in key global governance forums, ensuring alignment with brand strategy and medical priorities Collaborate with local marketing, digital, medical, and policy leads in priority markets to ensure seamless strategy execution and shared ownership of outcomes Leadership & Ways of Working We are looking for a leader who delivers results through partnership, clarity, and empowerment. Lead with a partnership mindset—building trust, alignment, and momentum across diverse teams and cultures Translate strategy into clear, actionable priorities and measurable outcomes, focusing on impact over activity Empower markets through scalable frameworks and capability building rather than central control Contribute to talent development by coaching, role - modeling inclusive leadership, and strengthening advocacy/market development capabilities across the network Education Required: Master’ s degree with scien tific expertise as preferred Desirable: Secondary degree, e.g., MBA, PhD with science expertise Experience Required: 10+ years experience in healthcare or biopharma industry, with a strong preference for experience in the Respiratory and/or Immunology area Confirmed experience of

Aday Kriterleri

Tecrübe
Tecrübeli / Tecrübesiz
Eğitim Seviyesi
Üniversite(Mezun)
Mülakat provası ikonu

Yapay zeka ile bu pozisyona özel mülakat provası yap.

Yapay zeka tarafından oluşturulan pozisyona özel sorularla mülakat provası yap, performansına dair anında geri bildirim al.

Yeni
ai Mülakat Provası Yap

Şirket Hakkında

Astrazeneca
İlaç Sanayi 4000 - 4999 Çalışan 15190 Takipçi

AstraZeneca “Yaşama değer katan ilaçları keşfetmek için bilimin sınırlarını zorluyoruz.” Dünyanın önde gelen yenilikçi ve araştırmacı ilaç şirketlerinden biri olarak, yıllık 23,1 milyar dolarlık sağlık hizmeti hacmimizle toplum sağlığına anlamlı bir değer katmak için çalışıyor, hasta odaklı yaklaşımımızla araştırma, geliştirme, reçeteli ilaçların üretimi, pazarlanması ve bu hizmetlerin sunulması alanlarında faaliyet gösteriyoruz.

Bu Pozisyon İçin Sık Paylaşılan Maaşlar

Maaş Detaylarını Gör
Kariyer.net'te son 3 ayda bu pozisyona başvuranların maaş beklentisi₺29.900-₺40.400
aralığındadır. Aralık tüm deneyim seviyelerini kapsamaktadır.
group Maaş verilerini geliştirmemize katkı sağla!
Kariyer Tavsiyeleri
Market Görevlisi pozisyonu ile ilgili daha detaylı bilgi almak için aşağıdaki sayfaları inceleyebilirsiniz.
Astrazeneca
İlaç Sanayi
closingDate:21.07.2026 lastPublishDate:22.06.2026